ClinicalTrials.Veeva

Menu

Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier (Ana-Ped)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Allergy
Anaphylaxis

Study type

Observational

Funder types

Other

Identifiers

NCT05112367
RECHMPL21_0613

Details and patient eligibility

About

Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its incidence is progressively increasing in the general population over years, especially among children. The diagnosis can be difficult, and recommendations for follow up and prescription for an emergency kit are rarely provided after emergency visit. The Investigators will evaluate the management of pediatric anaphylaxis and clinical signs of allergy in the pediatric emergency department of Montpellier University Hospital

Enrollment

2,500 estimated patients

Sex

All

Ages

2 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients evaluated at the Montpellier University Hospital, Allergy Unit ;
  • Children consulting for suspected allergy from 2016 to 2020

Exclusion criteria

  • Patients under legal protection, under guardianship or under curatorship;

Trial contacts and locations

1

Loading...

Central trial contact

Evangéline CLARK, doctor; Davide CAIMMI, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems